A synthesis route toward 2-deoxystreptamine, a common structure in many of the clinically important aminoglycosides, is presented. Starting from p-benzoquinone and cyclopentadiene, 2-deoxystreptamine is synthesized with key steps involving Pd(0)-catalyzed rearrangement, a retro-Diels-Alder by flash vacuum thermolysis, and Yb(III)-directed regioselective epoxide opening. The obtained diazidocyclitol 17 is a suitable 2-deoxystreptamine precursor, conveniently protected for incorporation in new aminoglycoside entities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jo049788k | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.
RSC Med Chem
March 2022
Université Côte d'Azur, CNRS, Institut de Chimie de Nice (ICN) Nice France
Article Synopsis
- The discovery of new scaffolds for selectively targeting RNA is crucial in medicinal chemistry, particularly for developing treatments for cancers linked to oncogenic miRNAs.
- Researchers created a new series of RNA ligands derived from the 2-deoxystreptamine scaffold, which is a component of the aminoglycoside neomycin, to target the biogenesis of pre-miR-372, which is associated with cancer.
- Some of these newly developed RNA ligands showed comparable biological activity to existing neomycin analogs, and their binding mechanisms with pre-miR-372 were investigated.
Metabolically engineered recombinant for the production of 2-Deoxy--inosose (2-DOI).
Metab Eng Commun
December 2020
Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, ON, M5S 3E5, Canada.
is a versatile industrial host for chemical production and has been engineered to produce efficiently many valuable compounds. 2-Deoxy--inosose (2-DOI) is an important precursor for the biosynthesis of 2-deoxystreptamine-containing aminoglycosides antibiotics and benzenoid metabolites. Bacterial and cyanobacterial strains have been metabolically engineered to generate 2-DOI; nevertheless, the production of 2-DOI using a yeast host has not been reported.
View Article and Find Full Text PDFThe oxidoreductases LivQ and NeoQ are responsible for the different 6'-modifications in the aminoglycosides lividomycin and neomycin.
J Appl Microbiol
September 2011
BU Wuppertal, FB-C, Chemical Microbiology AG, Piepersberg, Wuppertal, Germany.
Aims: The 2-deoxystreptamine-containing aminoglycoside antibiotics (AGAs) constitute the largest subgroup of the aminoglycosides. Neomycin (NEO) and lividomycin (LIV) are both representatives of the pseudo-tetrasaccharide group among the NEO-type AGAs. While NEO contains a 6'-NH(2) group, the 6'-position remains unmodified in LIV.
View Article and Find Full Text PDFAsymmetric desymmetrization of 4,5-epoxycyclohex-1-ene by enantioselective allylic oxidation.
Org Lett
August 2009
Department of Frontier Research and Technology, Headquarters for Innovative Cooperation and Development, Kobe University, Nada, Kobe 657-8501, Japan.
Asymmetric desymmetrization of allylic oxidation of 4,5-epoxycyclohex-1-ene (1) took place in the presence of 2.5 mol % of Cu(CH(3)CN)(4)PF(6) and 3 mol % of chiral N,N-bidentate ligand (S)-2 to afford (3S,4S,5S)-3-benzoyloxy-4,5-epoxycyclohex-1-ene (3) in 84% ee, which was increased up to >99% ee after recrystallization of 3-4'-nitrobenzoyloxy derivative 6. Optically pure 6 proved to be a key intermediate for enantioselective synthesis of O-protected 2-deoxystreptamine (2-DOS) precursor 12.
View Article and Find Full Text PDFThe neomycin biosynthetic gene cluster of Streptomyces fradiae NCIMB 8233: genetic and biochemical evidence for the roles of two glycosyltransferases and a deacetylase.
Org Biomol Chem
September 2008
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge, CB2 1GA, United Kingdom.
An efficient protocol has been developed for the genetic manipulation of Streptomyces fradiae NCIMB 8233, which produces the 2-deoxystreptamine (2-DOS)-containing aminoglycoside antibiotic neomycin. This has allowed the in vivo analysis of the respective roles of the glycosyltransferases Neo8 and Neo15, and of the deacetylase Neo16 in neomycin biosynthesis. Specific deletion of each of the neo8, neo15 and neo16 genes confirmed that they are all essential for neomycin biosynthesis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!